RelB Antibody Blocking Peptide(bs-3562P)-500ug产品图

RelB Antibody Blocking Peptide

(bs-3562P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-3562P
  • 2025年10月16日
    avatar
    品牌商
    10钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      500ug

    产品编号bs-3562P
    英文名称RelB Antibody Blocking Peptide
    中文名称核转录因子NFKB-RelB蛋白封闭多肽
    英文别名Rel B; I REL; IREL; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; RelB; Reticuloendotheliosis viral oncogene homolog B; Transcription factor RelB; v rel avian reticuloendotheliosis viral oncogene homolog; v rel reticuloendotheliosis viral oncogene homolog B; RELB_HUMAN; I-Rel.
    纯化方法HPLC
    研究领域

    Cancer > Cell Death > Apoptosis > Apoptosis Markers > NFkB > RelB

    Cancer > Oncoproteins/suppressors > Oncoproteins > Transcription factors

    Cancer > Signal transduction > Nuclear signaling > NFkB pathway

    Cell Biology > Apoptosis > Intracellular > NFkB > RelB

    Epigenetics and Nuclear Signaling > Nuclear Signaling Pathways > NFkB pathway

    Epigenetics and Nuclear Signaling > Transcription > Transcription Factors

    Signal Transduction > Signaling Pathway > Nuclear Signaling > NFkB Pathway

    亚基Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.
    亚细胞定位Nucleus. Cytoplasm, cytoskeleton, centrosome. Note=Co-localizes with NEK6 in the centrosome.
    翻译后修饰Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation.
    相似性Contains 1 RHD (Rel-like) domain.
    功能NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料The NFKB complex consists of NFKB1 or NFKB2 bound to REL, RELA, or RELB. The NFKB complex is inhibited by I kappa B proteins (NFKBIA, or NFKBIB), which inactivate NF kappa B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I kappa B proteins by kinases (IKBKA, or IKBKB,) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF kappa B complex.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥3692
    武汉博欧特生物科技有限公司
    2025年07月12日询价
    ¥4513.50
    深圳欣博盛生物科技有限公司
    2025年07月12日询价
    ¥1
    瑞博奥(广州)生物科技股份有限公司
    2025年07月11日询价
    ¥3784.50
    西宝生物科技(上海)股份有限公司
    2025年07月04日询价
    RelB Antibody Blocking Peptide(bs-3562P)-500ug
    ¥880